{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:08:05Z","timestamp":1747454885119,"version":"3.40.5"},"reference-count":18,"publisher":"Sociedade Brasileira de Cardiologia","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,7]]},"DOI":"10.36660\/abc.20210167","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T14:53:35Z","timestamp":1657551215000},"page":"128-132","source":"Crossref","is-referenced-by-count":0,"title":["Reinerva\u00e7\u00e3o ap\u00f3s Denerva\u00e7\u00e3o Renal \u2013 Um Mito?"],"prefix":"10.36660","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-6622","authenticated-orcid":false,"given":"Eric","family":"Monteiro","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7065-9773","authenticated-orcid":false,"given":"Joana","family":"Delgado-Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-3690","authenticated-orcid":false,"given":"Gon\u00e7alo","family":"Costa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-3064","authenticated-orcid":false,"given":"Lino","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]}],"member":"22636","reference":[{"issue":"2","key":"key20220711105330_B1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015","volume":"317","author":"Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317(2):165-82. doi: 10.1001\/jama.2016.19043.","journal-title":"JAMA"},{"issue":"2","key":"key20220711105330_B2","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S2468-2667(18)30210-X","article-title":"Burden of hypertension and associated risks for cardiovascular mortality in Cuba: a prospective cohort study","volume":"4","author":"Armas Rojas","year":"2019","unstructured":"Armas Rojas N, Dobell E, Lacey B, Varona-P\u00e9rez P, Burrett JA, Lorenzo-V\u00e1zquez E, et al. Burden of hypertension and associated risks for cardiovascular mortality in Cuba: a prospective cohort study. The Lancet Public Health. 2019;4(2):e107-e15. doi: 10.1016\/S2468-2667(18)30210-X. Epub 2019 Jan 23.","journal-title":"The Lancet Public Health"},{"issue":"4","key":"key20220711105330_B3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/HYPERTENSIONAHA.117.10662","article-title":"Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment)","volume":"71","author":"Krieger","year":"2018","unstructured":"Krieger EM, Drager LF, Giorgi DMA, Pereira AC, Barreto-Filho JAS, Nogueira AR, et al. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment). Hypertension. 2018;71(4):681-90. doi: 10.1161\/HYPERTENSIONAHA.117.10662.","journal-title":"Hypertension"},{"issue":"13","key":"key20220711105330_B4","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","unstructured":"Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635-42. doi: 10.1161\/CIRCULATIONAHA.111.068064.","journal-title":"Circulation"},{"issue":"33","key":"key20220711105330_B5","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)","volume":"39","author":"Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal. 2018;39(33):3021-104. doi: 10.1093\/eurheartj\/ehy339.","journal-title":"European Heart Journal"},{"issue":"4","key":"key20220711105330_B6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.14797\/mdcj-11-4-240","article-title":"Resistant Hypertension and Renal Nerve Denervation","volume":"11","author":"Denker","year":"2015","unstructured":"Denker MG, Cohen DL. Resistant Hypertension and Renal Nerve Denervation. Methodist DeBakey Cardiovasc J. 2015;11(4):240-4. doi: 10.14797\/mdcj-11-4-240.","journal-title":"Methodist DeBakey Cardiovasc J"},{"issue":"1","key":"key20220711105330_B7","doi-asserted-by":"crossref","first-page":"15505","DOI":"10.1038\/s41598-018-33783-3","article-title":"Predictors for success in renal denervation\u2013a single centre retrospective analysis","volume":"8","author":"Reshetnik","year":"2018","unstructured":"Reshetnik A, Gohlisch C, Scheurig-M\u00fcnkler C, De Bucourt M, Zidek W, T\u00f6lle M, et al. Predictors for success in renal denervation\u2013a single centre retrospective analysis. Sci Rep. 2018;8(1):15505.","journal-title":"Sci Rep"},{"issue":"3","key":"key20220711105330_B8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2013.04.010","article-title":"Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis","volume":"62","author":"Davis","year":"2013","unstructured":"Davis MI, Filion KB, Zhang D, Eisenberg MJ, Afilalo J, Schiffrin EL, et al. Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62(3):231-41. doi: 10.1016\/j.jacc.2013.04.010.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20220711105330_B9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.17219\/acem\/58998","article-title":"Resistant Hypertension","volume":"25","author":"Doroszko","year":"2016","unstructured":"Doroszko A, Janus A, Szahidewicz-Krupska E, Mazur G, Derkacz A. Resistant Hypertension. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2016;25(1):173-83. doi: 10.17219\/acem\/58998.","journal-title":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University"},{"issue":"4","key":"key20220711105330_B10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.repc.2013.09.008","article-title":"Desnerva\u00e7\u00e3o renal em doentes com hipertens\u00e3o arterial resistente: resultados aos seis meses de seguimento","volume":"33","author":"Dores","year":"2014","unstructured":"Dores H, de Sousa Almeida M, de Ara\u00fajo Gon\u00e7alves P, Branco P, Gaspar A, Sousa H, et al. Desnerva\u00e7\u00e3o renal em doentes com hipertens\u00e3o arterial resistente: resultados aos seis meses de seguimento. Rev Port Cardiol. 2014;33(4):197-204. doi: 10.1016\/j.repc.2013.09.008","journal-title":"Rev Port Cardiol"},{"issue":"9756","key":"key20220711105330_B11","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Esler","year":"2010","unstructured":"Esler MD, Krum H, Sobotka PA, Schlaich M, Schmieder RE, Bohm M, Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903-9. doi: 10.1016\/S0140-6736(10)62039-9.","journal-title":"Lancet"},{"issue":"10137","key":"key20220711105330_B12","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","article-title":"Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial","volume":"391","author":"Kandzari","year":"2018","unstructured":"Kandzari DE, B\u00f6hm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391(10137):2346-55. doi: 10.1016\/S0140-6736(18)30951-6","journal-title":"Lancet"},{"issue":"10108","key":"key20220711105330_B13","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","article-title":"Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial","volume":"390","author":"Townsend","year":"2017","unstructured":"Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390(10108):2160-70. doi: 10.1016\/S0140-6736(17)32281-X.","journal-title":"Lancet"},{"issue":"10137","key":"key20220711105330_B14","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","unstructured":"Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391(10137):2335-45. doi: 10.1016\/S0140-6736(18)31082-1.","journal-title":"Lancet"},{"issue":"5","key":"key20220711105330_B15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCRESAHA.119.314695","article-title":"Now That Renal Denervation Works, How Do We Proceed?","volume":"124","author":"Papademetriou","year":"2019","unstructured":"Papademetriou V, Stavropoulos K, Doumas M, Tsioufis K. Now That Renal Denervation Works, How Do We Proceed? Circ Res. 2019;124(5):693-5. doi: 10.1161\/CIRCRESAHA.119.314695.","journal-title":"Circ Res"},{"issue":"5","key":"key20220711105330_B16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1113\/expphysiol.2014.079871","article-title":"Reinnervation following catheter-based radio-frequency renal denervation","volume":"100","author":"Booth","year":"2015","unstructured":"Booth LC, Nishi EE, Yao ST, Ramchandra R, Lambert GW, Schlaich MP, et al. Reinnervation following catheter-based radio-frequency renal denervation. Exp Physiol. 2015;100(5):485-90. doi: 10.1113\/expphysiol.2014.079871.","journal-title":"Exp Physiol"},{"issue":"5","key":"key20220711105330_B17","first-page":"R353","article-title":"Functional reinnervation and development of supersensitivity to NE after renal denervation in rats","volume":"238","author":"Kline","year":"1980","unstructured":"Kline RL, Mercer PF. Functional reinnervation and development of supersensitivity to NE after renal denervation in rats. Am J Physiol. 1980;238(5):R353-8.doi;10.1152\/ajpregu.1980.238.5.R353.","journal-title":"Am J Physiol"},{"issue":"9917","key":"key20220711105330_B18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","article-title":"Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study","volume":"383","author":"Krum","year":"2014","unstructured":"Krum H, Schlaich MP, Sobotka PA, B\u00f6hm M, Mahfoud F, Rocha-Singh K, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014;383(9917):622-9.","journal-title":"Lancet"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/reinervacao-apos-denervacao-renal-um-mito\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:09:53Z","timestamp":1747400993000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/reinervacao-apos-denervacao-renal-um-mito\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7,7]]}},"alternative-id":["10.36660\/abc.20210167"],"URL":"https:\/\/doi.org\/10.36660\/abc.20210167","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}